Not applicableAvailableNCT02355782What this trial is testingOMS721 Compassionate Use in Patients With Thrombotic MicroangiopathyWho this might be right forThrombotic Microangiopathy Michal Nowicki
Not applicableApproved For MarketingNCT04247906What this trial is testingSingle Patient Expanded Access Treatment Plan For The Investigational Product NarsoplimabWho this might be right forHematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA) Omeros Corporation
Not applicableNot Yet RecruitingNCT07381205What this trial is testingAssessing the Incidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Adult Patients Undergoing Allogeneic Stem Cell Transplant (SCT)Who this might be right forTransplant Associated Microangiopathy TAMTransplant Complication Manuel Ricardo Espinoza-Gutarra 85
Testing effectiveness (Phase 2)Looking for participantsNCT07707687What this trial is testingSafety and Efficacy of Eculizumab in High-risk TA-TMAWho this might be right forTransplant-Associated Thrombotic Microangiopathy (TA-TMA) First Affiliated Hospital of Zhejiang University 24
Not applicableLooking for participantsNCT07347990What this trial is testingSafety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic MicroangiopathyWho this might be right forThrombotic MicroangiopathyHematopoietic Stem Cell Transplantation (HSCT) First Affiliated Hospital of Zhejiang University 30
Testing effectiveness (Phase 2)Study completedNCT03518203What this trial is testingEculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant RecipientsWho this might be right forThrombotic MicroangiopathiesAtypical Hemolytic Uremic SyndromeMultiple Organ Dysfunction Syndrome Children's Hospital Medical Center, Cincinnati 23
Large-scale testing (Phase 3)Study completedNCT04543591What this trial is testingRavulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantWho this might be right forThrombotic Microangiopathy Alexion Pharmaceuticals, Inc. 148
Not applicableLooking for participantsNCT07059026What this trial is testingThrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult PatientsWho this might be right forThrombotic Microangiopathy ITAC (Instituto de Trasplantes y Alta Complejidad) 200
Not applicableLooking for participantsNCT06102694What this trial is testingIdentification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic MicroangiopathyWho this might be right forThrombotic MicroangiopathiesHematopoietic Stem Cell Transplantation Institute of Hematology & Blood Diseases Hospital, China 500
Not applicableWithdrawnNCT04970004What this trial is testingStudy in Adult and Pediatric Patients With HSCT-TMAWho this might be right forStem Cell Transplant ComplicationsThrombotic Microangiopathies Alexion Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT05148299What this trial is testingPegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantationWho this might be right forTransplant-Associated Thrombotic Microangiopathy Swedish Orphan Biovitrum 12